| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $41.8M | -4.3% |
| SG&A Expense | $11.0M | -8.4% |
| Operating Income | -$52.9M | +5.2% |
| Pre-tax Income | -$43.0M | +9.5% |
| Net Income | -$43.0M | +9.5% |
| EPS (Basic) | -$0.52 | +13.3% |
| EPS (Diluted) | -$0.52 | +13.3% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $132.2M | -12.5% |
| Total Assets | $135.6M | -12.2% |
| Total Liabilities | $15.3M | +22.1% |
| Stockholders' Equity | $120.3M | -15.2% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.8M | -10.9% |
| Financing Cash Flow | $12.0M | -59.6% |